ATE298801T1 - Fibrinogenproduktion in transgenen tieren - Google Patents
Fibrinogenproduktion in transgenen tierenInfo
- Publication number
- ATE298801T1 ATE298801T1 AT95912701T AT95912701T ATE298801T1 AT E298801 T1 ATE298801 T1 AT E298801T1 AT 95912701 T AT95912701 T AT 95912701T AT 95912701 T AT95912701 T AT 95912701T AT E298801 T1 ATE298801 T1 AT E298801T1
- Authority
- AT
- Austria
- Prior art keywords
- fibrinogen
- dna segments
- human
- transgenic animals
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/103—Ovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/206,176 US5639940A (en) | 1994-03-03 | 1994-03-03 | Production of fibrinogen in transgenic animals |
| PCT/US1995/002648 WO1995023868A1 (en) | 1994-03-03 | 1995-03-01 | Production of fibrinogen in transgenic animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298801T1 true ATE298801T1 (de) | 2005-07-15 |
Family
ID=22765288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95912701T ATE298801T1 (de) | 1994-03-03 | 1995-03-01 | Fibrinogenproduktion in transgenen tieren |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5639940A (de) |
| EP (1) | EP0748386B9 (de) |
| JP (1) | JPH09509839A (de) |
| CN (1) | CN1079433C (de) |
| AT (1) | ATE298801T1 (de) |
| AU (1) | AU685250B2 (de) |
| BR (1) | BR9506944A (de) |
| CA (1) | CA2184004C (de) |
| CZ (1) | CZ296382B6 (de) |
| DE (1) | DE69534295T4 (de) |
| DK (1) | DK0748386T4 (de) |
| ES (1) | ES2245453T5 (de) |
| FI (1) | FI963419L (de) |
| HU (1) | HU224550B1 (de) |
| NO (1) | NO329072B1 (de) |
| NZ (1) | NZ282601A (de) |
| PL (1) | PL186074B1 (de) |
| PT (1) | PT748386E (de) |
| SK (1) | SK111896A3 (de) |
| WO (1) | WO1995023868A1 (de) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0759762A4 (de) * | 1994-05-02 | 1999-09-01 | Squibb & Sons Inc | Rekombinante fibrinketten, fibrin und fibrinhomologe |
| US5968809A (en) | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| GB9715064D0 (en) * | 1997-07-17 | 1997-09-24 | Ppl Therapeutics Scotland Ltd | Protein expression |
| WO1999044625A1 (en) | 1998-03-03 | 1999-09-10 | John Hopkins University | Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation |
| US7122620B1 (en) * | 1998-05-27 | 2006-10-17 | Medical Research Services And Development Ltd. | Haptotactic peptides |
| JP2003517809A (ja) * | 1998-05-27 | 2003-06-03 | ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド | 新規ペプチド |
| DK1115745T3 (da) * | 1998-09-24 | 2006-10-02 | Pharming Intellectual Pty Bv | Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi |
| AU765315B2 (en) | 1998-11-19 | 2003-09-18 | Pharming Intellectual Property Bv | Stabilisation of milk from transgenic animals |
| GB9825374D0 (en) * | 1998-11-19 | 1999-01-13 | Ppl Therapeutics Scotland Ltd | Method |
| US7208576B2 (en) * | 1999-01-06 | 2007-04-24 | Merrimack Pharmaceuticals, Inc. | Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| ATE380467T1 (de) | 1999-01-06 | 2007-12-15 | Merrimack Pharmaceuticals Inc | Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren |
| US6183803B1 (en) | 1999-06-11 | 2001-02-06 | Biosante Pharmaceuticals, Inc. | Method for processing milk |
| JP2003511048A (ja) * | 1999-10-14 | 2003-03-25 | ジェンジム トランスジェニックス コーポレイション | 遺伝子導入された動物中において標的分子を産生する方法および該標的分子を精製する方法 |
| US7074983B2 (en) | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
| US7414170B2 (en) | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
| CA2395779A1 (en) * | 1999-12-27 | 2001-07-05 | Curagen Corporation | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| IL152697A0 (en) * | 2000-05-13 | 2003-06-24 | Bioacta Ltd | Anti-angiogenic polypeptides |
| WO2002018440A1 (en) * | 2000-09-01 | 2002-03-07 | Bioacta Limited | Anti-angiogenic peptides |
| WO2002026932A2 (en) | 2000-09-26 | 2002-04-04 | Duke University | Rna aptamers and methods for identifying the same |
| NZ525664A (en) * | 2000-11-17 | 2008-08-29 | Kirin Holdings Kk | Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| US20020073441A1 (en) | 2000-12-13 | 2002-06-13 | Ross Brian D. | Compositions and methods for detecting proteolytic activity |
| EP1497418B1 (de) | 2002-04-19 | 2012-10-17 | Verenium Corporation | Phospholipasen, diese codierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung |
| US7226771B2 (en) | 2002-04-19 | 2007-06-05 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
| DE10261126A1 (de) * | 2002-08-13 | 2004-03-04 | Aventis Behring Gmbh | Lagerungsstabile, flüssige Fibrinogen-Formulierung |
| IL152609A0 (en) * | 2002-11-03 | 2003-06-24 | Hapto Biotech Inc | Liposomal compositions comprising haptotactic peptides and uses thereof |
| EP1563084A4 (de) | 2002-11-08 | 2006-03-01 | Hematech Llc | Transgene ungulaten mit reduzierter prionproteinaktivität und verwendungen davon |
| DE60331857D1 (de) * | 2002-12-24 | 2010-05-06 | Nitto Boseki Co Ltd | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit |
| EP2194133B1 (de) | 2003-03-06 | 2015-12-02 | BASF Enzymes LLC | Amylasen, Nukleinsäuren, die diese codieren, und Verfahren zu deren Herstellung und Verwendung |
| CA2515583C (en) | 2003-03-07 | 2015-07-14 | Diversa Corporation | Hydrolases, nucleic acids encoding them and methods for making and using them |
| EP1613733B1 (de) | 2003-04-04 | 2015-06-03 | BASF Enzymes LLC | Pektatlyasen, diese codierende nukleinsäuren und verfahren zu deren herstellung und verwendung |
| US7514593B2 (en) | 2003-05-30 | 2009-04-07 | The University Of North Carolina At Chapel Hill | Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
| CN103484486B (zh) | 2003-07-02 | 2018-04-24 | 维莱尼姆公司 | 葡聚糖酶,编码它们的核酸以及制备和使用它们的方法 |
| US7741089B2 (en) | 2003-08-11 | 2010-06-22 | Verenium Corporation | Laccases, nucleic acids encoding them and methods for making and using them |
| AU2004271200A1 (en) * | 2003-09-05 | 2005-03-17 | Gtc Biotherapeutics, Inc. | Method for the production of fusion proteins in transgenic mammal milk |
| US20050186608A1 (en) * | 2004-02-19 | 2005-08-25 | Olsen Byron V. | Method for the production of transgenic proteins useful in the treatment of obesity and diabetes |
| DE102004009400A1 (de) | 2004-02-24 | 2005-09-08 | Zlb Behring Gmbh | Fibrinogen Reinigung |
| US7420099B2 (en) | 2004-04-22 | 2008-09-02 | Kirin Holdings Kabushiki Kaisha | Transgenic animals and uses thereof |
| AU2005264938B2 (en) | 2004-06-16 | 2011-11-24 | Verenium Corporation | Compositions and methods for enzymatic decolorization of chlorophyll |
| EP1869174B1 (de) | 2005-03-10 | 2015-02-18 | BASF Enzymes LLC | Lyase-enzyme, nukleinsäuren zu deren kodierung und verfahren zu deren herstellung und verwendung |
| US7794659B2 (en) * | 2005-03-10 | 2010-09-14 | Gen-Probe Incorporated | Signal measuring system having a movable signal measuring device |
| EA018577B1 (ru) | 2005-03-15 | 2013-09-30 | Верениум Корпорейшн | Целлюлазы, нуклеиновые кислоты, кодирующие их, и способы их получения и применения |
| EP1987142A4 (de) | 2006-02-02 | 2009-07-15 | Verenium Corp | Esterasen und damit zusammenhängende nukleinsäuren und verfahren |
| NZ595502A (en) | 2006-02-10 | 2013-11-29 | Verenium Corp | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| ES2682284T3 (es) | 2006-02-14 | 2018-09-19 | Bp Corporation North America Inc. | Xilanasas, ácidos nucleicos que las codifican y métodos para elaborarlas y usarlas |
| RU2008139428A (ru) | 2006-03-06 | 2010-05-20 | Хьюмэджин, Инк. (Us) | Способ получения рекомбинантного тромбина и фибриногена человека |
| ES2416104T3 (es) | 2006-03-07 | 2013-07-30 | Cargill, Incorporated | Aldolasas, ácidos nucleicos que las codifican y métodos para producir y usar las mismas |
| KR101622894B1 (ko) | 2006-03-07 | 2016-05-19 | 바스프 엔자임스 엘엘씨 | 알돌라제, 이것을 코딩하는 핵산과 그 제조 방법 및 사용 방법 |
| US8124831B2 (en) * | 2006-07-06 | 2012-02-28 | Duke University | Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase |
| CN106222185B (zh) | 2006-08-04 | 2021-12-03 | 维莱尼姆公司 | 葡聚糖酶、编码它们的核酸及制备和使用它们的方法 |
| US8877478B2 (en) | 2006-09-21 | 2014-11-04 | Verenium Corporation | Phytases, nucleic acids encoding them and methods for making and using them |
| EP2057274B1 (de) | 2006-09-21 | 2013-12-11 | DSM IP Assets B.V. | Phospholipase ,nukleinsaüre, die diese kodieren und verfahren zur ihrer herstellung und verwendung |
| PL3101128T3 (pl) | 2006-12-21 | 2019-09-30 | Basf Enzymes Llc | Amylazy i glukoamylazy, kwasy nukleinowe kodujące te związki oraz sposoby wytwarzania tych związków oraz stosowania ich |
| DK2623605T3 (en) | 2007-04-09 | 2019-03-25 | Univ Florida | RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF |
| NZ601191A (en) | 2007-10-03 | 2014-01-31 | Verenium Corp | Xylanases, nucleic acids encoding them and methods for making and using them |
| CA2739011A1 (en) * | 2007-10-29 | 2009-05-07 | The Regents Of The University Of California | Osteoarthritis gene therapy |
| CA2710922A1 (en) | 2008-01-03 | 2009-07-16 | Verenium Corporation | Isomerases, nucleic acids encoding them and methods for making and using them |
| AU2008347234B2 (en) | 2008-01-03 | 2015-05-28 | Basf Enzymes Llc | Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| US8557773B2 (en) | 2008-05-02 | 2013-10-15 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Treatment of bleeding with low half-life fibrinogen |
| AU2009268052B2 (en) * | 2008-07-09 | 2015-05-28 | Mallinckrodt Pharma Ip Trading D.A.C. | Recombinant fibrinogen |
| US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8198062B2 (en) | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| AU2009290563A1 (en) | 2008-09-15 | 2010-03-18 | Genentech, Inc. | Compositions and methods for regulating cell osmolarity |
| HUE030948T2 (en) | 2009-05-21 | 2017-06-28 | Basf Enzymes Llc | Phytases, nucleic acids and processes encoding them for their production and use |
| US20100304873A1 (en) * | 2009-05-28 | 2010-12-02 | Lipa Markowitz | Bowling Ball and Football Game Controller |
| UA109884C2 (uk) | 2009-10-16 | 2015-10-26 | Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування | |
| UA111708C2 (uk) | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | Спосіб рафінування олії |
| US20130011382A1 (en) | 2010-01-08 | 2013-01-10 | Profibrix Bv | Fibrinogen Preparations Enriched In Fibrinogen With An Extended Alpha Chain |
| EP2547337A1 (de) | 2010-03-17 | 2013-01-23 | Pharming Intellectual Property B.V. | Verwendung von antikoagulanzien bei der herstellung von rekombinanten proteinen in der milch von transgenen tieren |
| HUE041571T2 (hu) | 2010-04-23 | 2019-05-28 | Univ Florida | RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére |
| EP2956003A2 (de) | 2013-02-13 | 2015-12-23 | Laboratoire Français du Fractionnement et des Biotechnologies | Proteine mit modifizierter glykosylierung und verfahren zur herstellung davon |
| KR20160002713A (ko) | 2013-02-13 | 2016-01-08 | 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 | 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도 |
| KR20160102060A (ko) * | 2013-12-24 | 2016-08-26 | 엘에프비 유에스에이, 인크. | 헤파린의 형질전환적 생성 |
| CN103995077B (zh) * | 2014-05-21 | 2016-01-27 | 中国计量科学研究院 | 一种测定奶粉中β-乳球蛋白含量的方法 |
| FR3032621A1 (fr) | 2015-02-13 | 2016-08-19 | Lab Francais Du Fractionnement | Colle biologique et son utilisation comme medicament |
| DK3270950T3 (da) * | 2015-03-20 | 2021-06-07 | Univ Paris | Isolerede peptider og fragmenter deraf fra fibrinogen til anvendelse som lægemidler, især ved inflammatoriske hudsygdomme |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| KR101841587B1 (ko) | 2016-01-12 | 2018-05-14 | 주식회사 녹십자홀딩스 | 피브리노겐의 정제방법 |
| CN118697858A (zh) | 2016-07-06 | 2024-09-27 | 法国血液分割暨生化制品实验室 | 稳定的液体纤维蛋白原 |
| ES2832881T3 (es) * | 2018-04-24 | 2021-06-11 | Fibriant B V | Variantes de fibrinógeno gamma prima para su uso en el tratamiento de una infección |
| CN114630579B (zh) | 2019-11-05 | 2024-12-17 | 弗尔斯蒂血液研究所基金会股份有限公司 | 胎儿/新生儿同种免疫性血小板减少症的鼠模型 |
| US11266129B2 (en) | 2019-11-05 | 2022-03-08 | Versiti Blood Research Institute Foundation, Inc. | Murine model of fetal/neonatal alloimmune thrombocytopenia |
| WO2024261097A1 (en) | 2023-06-20 | 2024-12-26 | Institut National de la Santé et de la Recherche Médicale | A new relevant non-human animal model of progressive metabolic dysfunction-associated steatotic liver disease (masld) and atherosclerosis development |
| CN121186363B (zh) * | 2025-11-25 | 2026-04-10 | 长兴固容生物科技有限公司 | 一种用于泛癌筛查、诊断的标志物组及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT359653B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
| AT359652B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4442655A (en) | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
| US4462567A (en) | 1982-10-28 | 1984-07-31 | Helmut Habicht | Discharge valve for granular materials |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| US4627879A (en) | 1984-09-07 | 1986-12-09 | The Trustees Of Columbia University In The City Of New York | Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5366894A (en) | 1986-06-30 | 1994-11-22 | Pharmaceutical Proteins Limited | Peptide production |
| GB8615942D0 (en) * | 1986-06-30 | 1986-08-06 | Animal & Food Research Council | Peptide production |
| EP0279582A3 (de) * | 1987-02-17 | 1989-10-18 | Pharming B.V. | DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten |
| US4873316A (en) * | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| CA1340740C (en) | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
| AT397203B (de) | 1988-05-31 | 1994-02-25 | Immuno Ag | Gewebeklebstoff |
| US5087353A (en) | 1988-11-03 | 1992-02-11 | Ecological Engineering Associates | Solar aquatic apparatus for treating waste |
| GB8826446D0 (en) * | 1988-11-11 | 1988-12-14 | Agricultural & Food Res | Peptide production |
| US5204447A (en) | 1988-11-14 | 1993-04-20 | Zymogenetics, Inc. | Purification of factor xiii |
| DE3928628C1 (de) | 1989-08-30 | 1990-10-11 | Kurt 5060 Bergisch Gladbach De Munny | |
| DE69027683T2 (de) * | 1989-12-01 | 1997-02-13 | Pharming Bv | Herstellung rekombinanter polypeptide durch rinder und transgene methoden |
| GB9028062D0 (en) * | 1990-12-24 | 1991-02-13 | Agricultural & Food Res | Production of transgenic animals |
| AU1228592A (en) * | 1991-01-11 | 1992-08-17 | American Red Cross | Expression of active human protein c in mammary tissue of transgenic animals |
| US5272074A (en) | 1992-04-23 | 1993-12-21 | Mcmaster University | Fibrin coated polymer surfaces |
-
1994
- 1994-03-03 US US08/206,176 patent/US5639940A/en not_active Ceased
-
1995
- 1995-03-01 BR BR9506944A patent/BR9506944A/pt not_active Application Discontinuation
- 1995-03-01 PT PT95912701T patent/PT748386E/pt unknown
- 1995-03-01 CZ CZ0257596A patent/CZ296382B6/cs not_active IP Right Cessation
- 1995-03-01 SK SK1118-96A patent/SK111896A3/sk unknown
- 1995-03-01 CN CN95191945A patent/CN1079433C/zh not_active Expired - Lifetime
- 1995-03-01 PL PL95316115A patent/PL186074B1/pl not_active IP Right Cessation
- 1995-03-01 JP JP7523049A patent/JPH09509839A/ja not_active Ceased
- 1995-03-01 FI FI963419A patent/FI963419L/fi not_active Application Discontinuation
- 1995-03-01 WO PCT/US1995/002648 patent/WO1995023868A1/en not_active Ceased
- 1995-03-01 ES ES95912701T patent/ES2245453T5/es not_active Expired - Lifetime
- 1995-03-01 EP EP95912701A patent/EP0748386B9/de not_active Expired - Lifetime
- 1995-03-01 HU HU9602404A patent/HU224550B1/hu not_active IP Right Cessation
- 1995-03-01 DE DE1995634295 patent/DE69534295T4/de not_active Expired - Lifetime
- 1995-03-01 DK DK95912701.0T patent/DK0748386T4/da active
- 1995-03-01 CA CA002184004A patent/CA2184004C/en not_active Expired - Lifetime
- 1995-03-01 AT AT95912701T patent/ATE298801T1/de active
- 1995-03-01 NZ NZ282601A patent/NZ282601A/en not_active IP Right Cessation
- 1995-03-01 AU AU19770/95A patent/AU685250B2/en not_active Expired
-
1996
- 1996-09-02 NO NO19963651A patent/NO329072B1/no not_active IP Right Cessation
-
1999
- 1999-01-15 US US09/232,488 patent/USRE42704E1/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69534295D1 (de) | Fibrinogenproduktion in transgenen tieren | |
| ATE140027T1 (de) | Herstellung rekombinanter polypeptide durch rinder und transgene methoden | |
| IL83028A (en) | Heterologous protein production in transgenic mammals'mammary glands | |
| EP0347431A4 (en) | Expression of proteins in milk | |
| ATE184647T1 (de) | Embryonische stammzelle zur herstellung von chimäre und transgen-ongulaten | |
| DE59712068D1 (de) | Verfahren zur herstellung von säugetieren mit definierten genetischen eigenschaften | |
| BR9710652A (pt) | Linhagens de célula de massa interna de célula derivadas de embriões de ungulados. | |
| CA2089661A1 (en) | Transgenic non-human animals capable of producing heterologous antibodies | |
| DK0527063T3 (da) | Produktion af et protein af interesse i mælken af et transgent pattedyr | |
| DE69835145D1 (de) | Transgene Mäuse die ein menschliche Antikörper exprimieren | |
| ATE405167T1 (de) | Kollagenherstellung in der milch von transgenen säugetieren | |
| DK0744891T3 (da) | Transgene fibrinogener | |
| DK326788D0 (da) | Fremgangsmaade til fremstilling af en cellelinje |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0748386 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 0748386 Country of ref document: EP |